Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Hospira, Inc.    HSP   US4410601003

HOSPIRA, INC.

 (HSP)

1
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisionsForum 
Latest news on HOSPIRA, INC.
4d ago HOSPIRA, INC.: Hospira Reappoints Dr. Sumant Ramachandra Chief Scientific Offic..
5d agoDJU.S. HOT STOCKS FUTURES: Hot stocks to watch
5d ago HOSPIRA, INC.: Today’s Research on HSP, ALKS, CLSN, THRX, and CHTP
5d agoDJU.S. HOT STOCKS FUTURES: Hot stocks to watch
05/08 HOSPIRA, INC.: Hospira Convenes Its 2013 Annual Meeting of Shareholders
05/06DJU.S. HOT STOCK FUTURES: Hot stocks to watch
05/01 HOSPIRA, INC.: Hospira Reports First-Quarter 2013 Results
05/01 HOSPIRA, INC.: Hospira Unveils Global Device Strategy
04/24 HOSPIRA, INC.: Hospira Marks Five Years of Biosimilars Success at 2013 BIO Inte..
04/17 HOSPIRA, INC.: Hospira to Present at Upcoming Investor Conferences
04/15 HOSPIRA, INC.: Hospira Names Matthew R. Stober Senior Vice President of Operati..
04/02 HOSPIRA, INC.: Hospira to Host Conference Call for First-Quarter 2013 Results
03/18 HOSPIRA, INC.: Hospira Obtains Six Months U.S. Pediatric Exclusivity for Preced..
03/18 HOSPIRA, INC.: Hospira Statement on Rocky Mount Plant Inspection
03/01 HOSPIRA, INC.: Hospira Announces Executive Changes
02/13 HOSPIRA, INC.: Hospira Reports Fourth-Quarter and Full-Year 2012 Results
02/05 HOSPIRA, INC.: Hospira to Present at Upcoming Investor Conferences
01/22 HOSPIRA, INC.: Hospira and Q Core Medical Sign International Distribution Agree..
2012 HOSPIRA, INC.: Hospira to Host Conference Call for Fourth-Quarter 2012 Results ..
2012 HOSPIRA, INC.: Hospira to Present at the J.P. Morgan 31st Annual Healthcare Con..
2012 HOSPIRA, INC.: Hospira Reports Third-Quarter 2012 Results
2012 HOSPIRA, INC.: Statement on Drug Shortages and Quality Commitment by Hospira CE..
2012 HOSPIRA, INC.: Hospira to Host Conference Call for Third-quarter 2012 Results
2012 HOSPIRA, INC.: Hospira to Present at the UBS Global Life Sciences Conference Se..
2012 HOSPIRA, INC.: Hospira to Acquire Active Pharmaceutical Ingredient Manufacturin..
2012 HOSPIRA, INC.: Hospira to Present at Upcoming Investor Conferences
2012 HOSPIRA, INC.: Hospira Announces U.S. Re-Launch Of Generic Oxaliplatin Injectio..
2012 HOSPIRA, INC.: Hospira Reports Second-Quarter 2012 Results
2012 EXCLUSIVE: Labor Dept looking into JPMorgan stable value fund
2012 HOSPIRA, INC.: Hospira to Host Conference Call for Second-quarter 2012 Results
2012 HOSPIRA, INC.: Hospira and Lancaster General Hospital Honored for Patient Safet..
2012 HOSPIRA, INC.: I.V. Clinical Integration Helps Deliver Safety, Efficiency And F..
2012 HOSPIRA, INC.: Hospira Convenes Its 2012 Annual Meeting of Shareholders
2012 HOSPIRA, INC.: Hospira to Present at Upcoming Investor Conferences
2012 HOSPIRA, INC.: Hospira Reports First-Quarter 2012 Results
2012 HOSPIRA, INC.: Hospira to Present at the Bank of America Merrill Lynch 2012 Hea..
2012 HOSPIRA, INC.: Hospira Infusion Pumps Ranked Top Devices in New KLAS Smart Pump..
2012 HOSPIRA, INC.: Hospira Names John B. Elliot Senior Vice President of Operations
2012 JPMorgan stable value fund exiting private mortgages
2012 HOSPIRA, INC.: Hospira to Host Conference Call for First-quarter 2012 Results
2012 HOSPIRA, INC.: Hospira's TheraDoc(TM) Clinical Surveillance System to Support I..
2012 HOSPIRA, INC.: Hospira Receives FDA Clearance for Symbiq™ 3.13 Infusion Pump
2012 HOSPIRA, INC.: Hospira Receives FDA Clearance for Symbiq(TM) 3.13 Infusion Pump
2012 HOSPIRA, INC.: Hospira Joins the Generic Pharmaceutical Association
2012 HOSPIRA, INC.: Hospira to Present at the Barclays Capital Global Healthcare Con..
2012DJFDA Allows Temporary Importation Of Doxil Alternative; Approves New Methotrex..
2012 HOSPIRA, INC.: Hospira Works With FDA to Help Avert Methotrexate Shortage; Ship..
2012DJFDA Allows Temporary Importation Of Doxil Alternative; Approves New Methotrex..
2012DJUS STOCK FUTURES: Hot stocks to watch
2012 HOSPIRA, INC.: Hospira Reports Fourth-Quarter and Full-Year 2011 Results
2012 HOSPIRA, INC.: Hospira Commends FDA on Draft Biosimilars Guidelines
2012 HOSPIRA, INC.: Hospira Names Richard Davies Chief Commercial Officer
2012 HOSPIRA, INC.: Hospira named a Top 50 Organization for Multicultural Business O..
2012 HOSPIRA, INC.: Hospira to Host Conference Call for Fourth-Quarter 2011 Results ..
2012 HOSPIRA, INC.: Law Offices of Howard G. Smith Announces Lead Plaintiff Deadline..
2012 HOSPIRA, INC.: Hospira Announces Start of U.S. Phase III Biosimilar EPO Clinica..
2011 HOSPIRA, INC.: Law Offices of Howard G. Smith Announces Lead Plaintiff Deadline..
2011 HOSPIRA, INC.: Harwood Feffer LLP Announces That a Securities Class Action Laws..
2011 HOSPIRA, INC.: CORRECTING and REPLACING Glancy Binkow & Goldberg LLP Announces ..
2011 HOSPIRA, INC.: Hospira to Host Conference Call for Fourth-Quarter 2011 Results ..
2011 HOSPIRA, INC.: Hospira to Present at the J.P. Morgan 30th Annual Healthcare Con..
2011 HOSPIRA, INC.: Hospira Board Announces Retirement of Executive Chairman and For..
2011 HOSPIRA, INC.: The Law Firm of Levi & Korsinsky Notifies Investors with Losses ..
2011 HOSPIRA, INC.: Faruqi & Faruqi, LLP Announces Investigation of Hospira, Inc.
2011 HOSPIRA, INC.: Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against..
2011 HOSPIRA, INC.: Hospira Announces U.S. Launch of Imipenem-Cilastatin for Injecti..
2011 HOSPIRA, INC.: Holzer Holzer & Fistel, LLC Announces Investigation into Hospira..
2011 HOSPIRA, INC.: Hospira Supports President Obama on Drug Shortages
2011 HOSPIRA, INC.: Hospira Reports Third-Quarter 2011 Results
2011 HOSPIRA, INC.: Hospira Announces Certain Preliminary Third-Quarter 2011 Results
2011 HOSPIRA, INC.: Hospira to Host Conference Call for Third-Quarter 2011 Results
2011 HOSPIRA I: Hospira Announces Positive Results From Phase I U.S. Clinical Trial ..
2011 HOSPIRA I: DURECT Completes Enrollment in Pivotal U.S. Phase III Trial for POSI..
2011 HOSPIRA I: Hospira to Host 2011 Investor Day
2011 HOSPIRA I: Hospira to Present at the Morgan Stanley Global Healthcare Conferenc..
1  2  3Next
Advertisement
Chart
Duration : Period :
Hospira, Inc. Technical Analysis Chart | HSP | US4410601003 | 4-Traders
Income Statement Evolution
Hospira, Inc. : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.